Literature DB >> 28370872

Observations on the blood pressure paradox in heart failure.

Hector O Ventura1, Franz H Messerli2,3,4, Carl J Lavie1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28370872     DOI: 10.1002/ejhf.818

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  2 in total

1.  Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF).

Authors:  Matteo Serenelli; Michael Böhm; Silvio E Inzucchi; Lars Køber; Mikhail N Kosiborod; Felipe A Martinez; Piotr Ponikowski; Marc S Sabatine; Scott D Solomon; David L DeMets; Olof Bengtsson; Mikaela Sjöstrand; Anna Maria Langkilde; Inder S Anand; Chern-En Chiang; Vijay K Chopra; Rudolf A de Boer; Mirta Diez; Andrej Dukát; Junbo Ge; Jonathan G Howlett; Tzvetana Katova; Masafumi Kitakaze; Charlotta E A Ljungman; Subodh Verma; Kieran F Docherty; Pardeep S Jhund; John J V McMurray
Journal:  Eur Heart J       Date:  2020-09-21       Impact factor: 29.983

Review 2.  Effect of sodium-glucose cotransporter-2 inhibitors on blood pressure in patients with heart failure: a systematic review and meta-analysis.

Authors:  Min Li; Tieci Yi; Fangfang Fan; Lin Qiu; Zhi Wang; Haoyu Weng; Wei Ma; Yan Zhang; Yong Huo
Journal:  Cardiovasc Diabetol       Date:  2022-07-25       Impact factor: 8.949

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.